Assessment of microfilarial loads in the skin of onchocerciasis patients after treatment with different regimens of doxycycline plus ivermectin. Debrah AY, Mand S, Marfo-Debrekyei Y, Larbi J, Adjei O, Hoerauf A. Filaria J. 2006 Feb 05;5:1. doi: 10.1186/1475-2883-5-1. PMID: 16457735
Impact of Eighteen-Year Varied Compliance to Onchocerciasis Treatment with Ivermectin in Sentinel Savannah Agrarian Communities in Kaduna State of Nigeria. Osue HO, Inabo HI, Yakubu SE, Audu PA, Galadima M, Odama LE, Musa D, Ado SA, Mamman M. ISRN Parasitol. 2013 Aug 25;2013:960168. doi: 10.5402/2013/960168. eCollection 2013. PMID: 27398386
Onchocerciasis Elimination: Progress and Challenges. Lakwo T, Oguttu D, Ukety T, Post R, Bakajika D. Res Rep Trop Med. 2020 Oct 07;11:81-95. doi: 10.2147/RRTM.S224364. eCollection 2020. PMID: 33117052
The Mectizan Donation Program - highlights from 2005. Alleman MM, Twum-Danso NA, Thylefors BI. Filaria J. 2006 Sep 27;5:11. doi: 10.1186/1475-2883-5-11. PMID: 17005039
Primary motives for demand of ivermectin drug in mass distribution programmes to control onchocerciasis. Abanobi O, Chukwuocha U, Onwuliri C, Opara K. N Am J Med Sci. 2011 Feb;3(2):89-94. doi: 10.4297/najms.2011.389. PMID: 22540073
